Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.
The enzyme, PEG-KYNase, does not directly kill cancer cells but instead empowers the immune system to eradicate unwanted cells on its own. PEG-KYNase is designed to degrade kynurenine, a metabolite produced by numerous tumors that … Read the rest »
A research team led by Texas ChE Professor George Georgiou has engineered an enzyme that safely treats prostate and breast cancer in animals and also lengthens the lifespan of models that develop chronic lymphocytic leukemia. The new treatment and results from preclinical trials are described in a paper published in the Nov. 21 issue of … Read the rest »
A team of engineers and scientists from the McKetta Department of Chemical Engineering is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved. The findings were reported in the journal Nature Medicine on Nov. 7.
The UT Austin team … Read the rest »
Texas ChE professor George Georgiou, the Laura Jennings Turner Chair in Engineering, has been named a Fellow of the National Academy of Inventors (NAI).
Election to NAI fellow status is a “professional distinction given to renowned academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made … Read the rest »
The department is pleased to announce top presenters for this year’s Graduate Student Seminar Series, as voted by attending first-year and third-year Ph.D. students:
Top Presenter
Ben Wendel (Georgiou Group)
A System Immunology Approach to the Development of Natural Immunity to Malaria
Ben’s research explores the progression of the immune system with age … Read the rest »
The American Academy of Arts and Sciences announced the election of new members this week, including biochemist and chemical engineering professor George Georgiou.
Georgiou has been recognized for paving the way for advances in medicine that improve people’s lives, with discoveries such as a technology that has been incorporated into drugs that fight macular degeneration … Read the rest »
Professor George Georgiou has received $1.7 million in funding from the Cancer Prevention and Research Institute of Texas (CPRIT) for the development of a therapeutic enzyme to help the body’s immune system eliminate cancer cells.
Certain cancer cells survive by keeping the immune system from recognizing and eliminating them through an immunosuppressive molecule called Kyn. … Read the rest »
George Georgiou, professor of chemical and biomedical engineering at The University of Texas at Austin, has been named Inventor of the Year by the university’s Office of Technology Commercialization.
The award recognizes Georgiou for commercializing industry-changing technologies, preparing students to follow in his footsteps and proving that What Starts Here Changes the World… Read the rest »
Nature Biotechnology ranked George Georgiou, a professor in the Cockrell School of Engineering, one of the world’s top 20 translational researchers in 2013.
Georgiou, a renowned biomedical engineer and molecular biologist, is a leading authority in the discovery, development and manufacturing of protein therapeutics. Nature Biotechnology recognized Georgiou for his output of U.S. and … Read the rest »
Professor George Georgiou is leading a team of researchers that recently received a $6.5 million grant from the U.S. Department of Defense and the Defense Threat Reduction Agency to accelerate the evaluation and development of new vaccines for emerging health threats.
Georgiou’s collaborators include the College of Natural Sciences’ Edward Marcotte, professor of chemistry … Read the rest »
